Department of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University (IMU), No.126, Jalan 19/155B, Bukit Jalil, 57000, Kuala Lumpur, Malaysia
*Corresponding author: anilpkunnath@gmail.com
Online published on 19 September, 2018.
Cancer is one of the leading causes of mortality across the world. One relatively new form of treatment that has demonstrated remarkable promise in recent years is cord blood transplantation. The quick availability of cord blood and less stringent matching compared to hematopoietic stem cell transplantation gives it an edge over other techniques which helped it to emerge as a potential alternative source of hematopoietic stem cells in stem cell transplantation.
HLA, HSC, UCBT, GVHD
